Consolidated Balance Sheets (Parentheticals) - USD ($) $ in Thousands		Dec. 31, 2025	Dec. 31, 2024
Available-for-Sale, Amortized Cost		$ 295,849	$ 376,265
Financing Receivable, Allowance for Credit Loss	[1]	$ 16,987	$ 20,449
Preferred stock, par value (in dollars per share)		$ 0.01	$ 0.01
Preferred stock, shares issued (in shares)		0	0
Preferred stock, shares outstanding (in shares)		0	0
Preferred stock, shares authorized (in shares)		5,000,000	5,000,000
Common stock, par value (in dollars per share)		$ 0.01	$ 0.01
Common stock, shares authorized (in shares)		75,000,000	75,000,000
Common stock, shares issued (in shares)		9,467,925	9,353,348
Common stock, shares outstanding (in shares)		9,467,925	9,353,348

[1] Allowance for credit losses on loans in 2023 reported using the CECL method and in 2022 reported using the incurred loss method.